HCC

CTD - Clinical Trials Data

Abbreviations

CELESTIAL
CABO vs PLB
L2

details

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
First author: G.K. Abou-Alfa

Link

NCT01908426

IMbrave150
ATEZ+BEVA vs sora
L1

details

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
First author: Richard S. Finn

Link

NCT03434379